Marlowe Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.83M Buy
83,730
+6,000
+8% +$522K 26.17% 2
2024
Q2
$8.28M Sell
77,730
-10,360
-12% -$994K 23.26% 3
2024
Q1
$8.56M Sell
88,090
-24,220
-22% -$2.13M 22.52% 3
2023
Q4
$8.8M Sell
112,310
-30,410
-21% -$2.07M 23.89% 1
2023
Q3
$8.95M Buy
142,720
+1,930
+1% +$127K 27.43% 2
2023
Q2
$9.05M Sell
140,790
-156,100
-53% -$8.8M 21.12% 2
2023
Q1
$15.7M Sell
296,890
-102,980
-26% -$5.05M 21.37% 1
2022
Q4
$16.8M Sell
399,870
-67,410
-14% -$2.82M 22.62% 1
2022
Q3
$17.1M Sell
467,280
-66,860
-13% -$2.98M 20.46% 3
2022
Q2
$22.8M Buy
534,140
+14,190
+3% +$676K 23.62% 1
2022
Q1
$28M Sell
519,950
-78,520
-13% -$4.57M 20.86% 1
2021
Q4
$43M Buy
598,470
+15,740
+3% +$987K 24.4% 1
2021
Q3
$33.2M Hold
582,730
19.74% 2
2021
Q2
$37.9M Sell
582,730
-66,230
-10% -$4.18M 24.66% 1
2021
Q1
$38.6M Sell
648,960
-23,120
-3% -$1.26M 22.86% 1
2020
Q4
$31.7M Hold
672,080
17.02% 2
2020
Q3
$22.3M Sell
672,080
-17,230
-2% -$594K 12.96% 3
2020
Q2
$22.3M Hold
689,310
13.26% 2
2020
Q1
$16.5M Sell
689,310
-39,110
-5% -$1.13M 11.2% 2
2019
Q4
$21.3M Sell
728,420
-17,910
-2% -$476K 11.06% 2
2019
Q3
$17.2M Sell
746,330
-862,100
-54% -$18.1M 9.4% 4
2019
Q2
$30.2M Hold
1,608,430
17.46% 1
2019
Q1
$28.8M Sell
1,608,430
-330,140
-17% -$5.51M 19.97% 2
2018
Q4
$26.4M Sell
1,938,570
-399,080
-17% -$5.72M 23.74% 2
2018
Q3
$35.5M Buy
2,337,650
+1,043,770
+81% +$17.8M 25.47% 1
2018
Q2
$22.4M Buy
1,293,880
+699,460
+118% +$13.5M 16.54% 3
2018
Q1
$12.1M Buy
+594,420
New +$11.8M 12.57% 4

Other funds holding LRCX

Marlowe Partners's LRCX Position: Q3 2024 in Review

Marlowe Partners increased its Lam Research (LRCX) stake by 7.7% in Q3 2024, buying an estimated $522K and bringing the position to 83,730 shares worth $6.83M. The position accounts for 26.17% of the portfolio, ranked #2.

Marlowe Partners first reported a position in LRCX in Q1 2018 and has held it in 27 quarters since. The position peaked at $43M in Q4 2021. 1,464 funds tracked by Wall St. Rank hold LRCX as of Q3 2024.

  • Marlowe Partners held 83,730 shares of Lam Research worth $6.83M as of Q3 2024.
  • Marlowe Partners bought 6,000 Lam Research shares in Q3 2024, an estimated $522K.
  • Lam Research made up 26.17% of Marlowe Partners's portfolio in Q3 2024, its #2 holding.
  • Marlowe Partners first reported a position in Lam Research in Q1 2018 and has held it in 27 quarters since.
  • Marlowe Partners's Lam Research position peaked at $43M in Q4 2021.
  • 1,464 funds tracked by Wall St. Rank held Lam Research as of Q3 2024.

Based on Marlowe Partners's 13F filing for Q3 2024, filed 13 Nov 2024.